Lv2
190 积分 2022-07-23 加入
First-in-human study to assess guselkumab (anti-IL-23 mAb) pharmacokinetics/safety in healthy subjects and patients with moderate-to-severe psoriasis
3天前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
11天前
已完结
NET-targeted therapy: effects, limitations, and potential strategies to enhance treatment efficacy
13天前
已完结
Cell type-specific roles of APOE4 in Alzheimer disease
13天前
已完结
High precision and cost-effective multiplex quantification of amyloid-β40, amyloid-β42, p181Tau, p217Tau, neurofilament light chain, and glial fibrillary acidic protein from plasma and serum
16天前
已完结
Circulating immune complexes: Their immunochemistry, biology, and detection in selected dermatologic and systemic diseases
19天前
已完结
BMP signalling in skeletal development, disease and repair
1个月前
已完结
Activins, Myostatin and Related TGF-β Family Members as Novel Therapeutic Targets for Endocrine, Metabolic and Immune Disorders
1个月前
已完结
Effects of bimagrumab, an activin receptor type II inhibitor, on pituitary neurohormonal axes
1个月前
已完结
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)
1个月前
已完结
皖公网安备34019202002308
